Cell Growth & Differentiation, Vol 7, Issue 1 53-64, Copyright © 1996 by American Association of Cancer Research

ARTICLES

The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression

JM Sterner, Y Tao, SB Kennett, HG Kim and JM Horowitz
Department of Molecular Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.

We have shown previously that a novel cell cycle-regulated histone H1 kinase activity, retinoblastoma kinase (RbK), associates with and phosphorylates the amino terminus of the Rb protein in G2-M. We have shown also that the amino terminus of p107, a Rb-related protein, does not associate with a similar kinase in vitro or in vivo. Here, we report that a RbK-like kinase associates with the amino terminus of p130, another Rb-related protein, only marginally. Moreover, the association of RbK with Rb in vitro is shown to require a discrete portion of the Rb amino terminus, amino acids 89-202. This region has been shown previously to be subject to inactivating mutations in retinoblastoma and to be required for Rb-mediated growth suppression in vitro. Taken together, these data indicate that the formation of Rb-RbK complexes may play an important role in Rb-mediated growth suppression. We have mapped two in vitro sites of Rb phosphorylation by RbK to sites that are phosphorylated in vivo and are targets of cyclin-dependent kinase phosphorylation in vitro. As such, at least some sites of RbK phosphorylation overlap with those of other proline-directed serine and threonine kinases. Consistent with this latter observation, we report that the trans-activation domain of c-myc is phosphorylated specifically by RbK in vitro at a site (serine 62) that is phosphorylated in vivo during G2-M, cell-cycle phases in which RbK activity is maximal.

This article has been cited by other articles:

				E. Batsche, J. Desroches, S. Bilodeau, Y. Gauthier, and J. Drouin Rb Enhances p160/SRC Coactivator-dependent Activity of Nuclear Receptors and Hormone Responsiveness J. Biol. Chem., May 20, 2005; 280(20): 19746 - 19756. [Abstract] [Full Text] [PDF]

				K. S. Moorefield, S. J. Fry, and J. M. Horowitz Sp2 DNA Binding Activity and trans-Activation Are Negatively Regulated in Mammalian Cells J. Biol. Chem., April 2, 2004; 279(14): 13911 - 13924. [Abstract] [Full Text] [PDF]

				J. Doostzadeh-Cizeron, R. Evans, S. Yin, and D. W. Goodrich Apoptosis Induced by the Nuclear Death Domain Protein p84N5 Is Inhibited by Association with Rb Protein Mol. Biol. Cell, October 1, 1999; 10(10): 3251 - 3261. [Abstract] [Full Text]

				V. L. Zacny, J. Wilson, and J. S. Pagano The Epstein-Barr Virus Immediate-Early Gene Product, BRLF1, Interacts with the Retinoblastoma Protein during the Viral Lytic Cycle J. Virol., October 1, 1998; 72(10): 8043 - 8051. [Abstract] [Full Text] [PDF]

				J. M. Sterner, S. Dew-Knight, C. Musahl, S. Kornbluth, and J. M. Horowitz Negative Regulation of DNA Replication by the Retinoblastoma Protein Is Mediated by Its Association with MCM7 Mol. Cell. Biol., May 1, 1998; 18(5): 2748 - 2757. [Abstract] [Full Text]

				V. GOUYER, S. GAZZéRI, I. BOLON, C. DREVET, C. BRAMBILLA, and E. BRAMBILLA Mechanism of Retinoblastoma Gene Inactivation in the Spectrum of Neuroendocrine Lung Tumors Am. J. Respir. Cell Mol. Biol., February 1, 1998; 18(2): 188 - 196. [Abstract] [Full Text]

				G. A. Otterson, W.-d. Chen, A. B. Coxon, S. N. Khleif, and F. J. Kaye Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function PNAS, October 28, 1997; 94(22): 12036 - 12040. [Abstract] [Full Text] [PDF]

				R. S. Cuevo, S. Garrett, and J. M. Horowitz Detection and Functional Characterization of p180, a Novel Cell Cycle Regulated Yeast Transcription Factor That Binds Retinoblastoma Control Elements J. Biol. Chem., February 7, 1997; 272(6): 3813 - 3822. [Abstract] [Full Text] [PDF]